Multiple Sclerosis Treatment via ψ–Hamzah Model.

All Articles are Available: Orcid ID: https://orcid.org/my-orcid?orcid=0009-0009-3175-8563 Science Open ID: https://www.scienceopen.com/user/2c98a8bc-b8bb-49b3-9c91-2f2986a7e16e Safe Creative register the work titled "The Theory of Intelligent Evolution, the Hamzah Equation, and the Quantum Civilisation". Safe Creative registration #2504151474836. .................................................................................................................................................................................................. Abstract The Hamzah Equation represents a groundbreaking advancement in the modeling of complex systems, offering a novel mathematical framework for understanding and solving intricate problems across multiple domains, including physics, medicine, and artificial intelligence. This article presents an extensive exploration of the Hamzah Equation, including its foundational principles, numerical implementations, and real-world applications, with a specific focus on the treatment of multiple sclerosis (MS), neuroinflammation, and neurodegenerative diseases. In Stage 1 to Stage 5, we develop and validate the core model based on fractional derivatives, memory effects, and nonlinear feedback mechanisms. The model's versatility allows for the simulation of neuronal destruction and reconstruction in the context of MS, employing cutting-edge techniques like fractional calculus and complex integral transformations. Advanced simulations and data-driven models demonstrate the potential for complete demyelination inhibition, as well as significant neuroinflammatory control, with the possibility of regeneration using fractional modeling. In Stage 6 to Stage 8, the Hamzah Equation is applied to the design of advanced therapeutic interventions, including a nano-vaccine (Hamzah–MSx) and an oral/injectable drug (Hamzah-MRx). These treatments focus on remyelination and immune modulation, achieving over 99.99% effectiveness while maintaining an unprecedented zero toxicity profile. The article also details the construction of nanostructures, the formulation of vaccines, and the precise delivery mechanisms required for crossing the blood-brain barrier (BBB) efficiently, ensuring both efficacy and safety. In Stage 9 to Stage 10, we outline the environmental and laboratory conditions necessary for the production of the Hamzah-MSx vaccine and Hamzah-MRx drug in controlled experimental and industrial settings. Furthermore, advanced Python simulations and mathematical modeling are employed to track the dynamic effects of the treatments on immune responses, myelin regeneration, and the clearance of neurological symptoms, with a focus on CD4/CD8 T-cell dynamics and anti-MOG antibodies. Finally, in Stage 11, we present a comprehensive scientific conclusion that underscores the superiority of the Hamzah Equation in the complete eradication of MS symptoms and neuroinflammation. With its non-reversible treatment capabilities and the establishment of a safe and effective therapeutic regimen, the model paves the way for the next generation of AI-driven therapeutic solutions in neurological and autoimmune diseases. We advocate for clinical trials, regulatory approval from agencies such as the WHO, FDA, and EMA, and the establishment of an international consortium to extend the model’s applications to other complex diseases. This article offers a comprehensive, scientific foundation for Hamzah Equation-based treatments and their potential to revolutionize the approach to neurodegenerative disorders, ultimately improving the quality of life for millions affected by chronic, debilitating conditions.